Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Acclinate

Explore full profile

Acclinate – Enhance the diversity of your clinical trials

Birmingham, United StatesFounded 2020Health Tech & Medtech
Valuation $25–50M Last recorded · 2024
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Acclinate and the history behind them.

About Acclinate

Acclinate is a startup operating in the healthcare sector, specifically in the realm of clinical trials. The company's primary mission is to increase the participation of communities of color in pharmaceutical trials and other health initiatives. Acclinate achieves this by combining cultural understanding with predictive software to identify, engage, and educate these communities about the importance and value of participating in clinical trials.

The company's business model is based on a three-step engagement process. Firstly, they focus on hard-to-reach communities and devise strategies to raise awareness and boost participation. Secondly, they engage and educate these communities about the potential benefits of participating in clinical trials. Lastly, they target interested community members for research opportunities they may qualify for and maintain engagement to inspire advocacy and keep the initiative at the forefront of their minds.

Acclinate's clients are primarily pharmaceutical companies and research institutions that require diverse participants for their clinical trials. By ensuring a more diverse participant pool, these trials can yield more comprehensive and inclusive results. The company generates revenue by charging these institutions for their services, which include participant recruitment, engagement, and education.

In summary, Acclinate is a healthcare startup that uses a culturally sensitive approach and predictive software to increase the participation of communities of color in clinical trials. They serve pharmaceutical companies and research institutions by providing them with a diverse pool of trial participants, thereby enhancing the inclusivity and comprehensiveness of their research.

Source: Dealroom company data

At a glance

Founded
2020
Headquarters
Birmingham, United States
Sector
Health Tech & Medtech

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Google for Startups Accelerator

Series A2 investors entered at this stage

  • Alabama Launchpad
  • Cencora Ventures
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States97.9%
🇨🇦 Canada2.1%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Acclinate on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Acclinate on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.